WILMINGTON, Del., March 16, 2012 /PRNewswire/ -- DuPont today announced that Lamberto Andreotti, CEO of Bristol-Myers Squibb, will be a nominee for election to its board of directors during the company's annual stockholders meeting on April 25.
"Lamberto leads a diverse, global business and understands the dynamics of the marketplace. DuPont will benefit from his experience and perspective as we provide science-powered innovations that address the challenges of food, energy and protection for the world's growing population," said DuPont Chair and CEO Ellen Kullman. "We look forward to the wealth of knowledge and insight that Lamberto will bring to the DuPont board."
Andreotti, 61, has been CEO of Bristol-Myers Squibb since 2010. He previously served as its president and chief operating officer responsible for all of Bristol-Myers Squibb's pharmaceutical operations worldwide. Andreotti, a member of Bristol-Myers Squibb's board of directors since 2009, has led a broad range of businesses and regions since joining the company in 1998. Andreotti earned his bachelor's degree in engineering from the University of Rome and a master's degree from the Massachusetts Institute of Technology.
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
For a high-res photo of Lamberto Andreotti, please click here.